InvestorsHub Logo
Followers 55
Posts 10572
Boards Moderated 6
Alias Born 11/14/2019

Re: None

Saturday, 10/01/2022 7:35:09 PM

Saturday, October 01, 2022 7:35:09 PM

Post# of 745
Bellerophon Provides Clinical Program Update and Reports First Quarter 2022 Financial Results
05/11/2022 12:30 PM
WARREN, N.J. , May 11, 2022 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLPH News